Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial

The optimal dose of fentanyl sublingual spray (FSS) for exertional dyspnea has not been determined.

Source: Journal of Pain and Symptom Management - July 1, 2019 Category: Palliative Care Authors: David Hui, Farley Hernandez, Liliana Larsson, Diane Liu, Kelly Kilgore, Jane Naberhuis, Avery Virgilio, Suresh Reddy, Akhila Reddy, Shalini Dalal, Ali Haider, Larry Driver, Ahsan Azhar, Rony Dev, Eduardo Bruera Source Type: research